An overview of the latest in state-of-the-art murine models for prostate cancer

Expert Opin Drug Discov. 2021 Nov;16(11):1349-1364. doi: 10.1080/17460441.2021.1943354. Epub 2021 Jul 5.

Abstract

Introduction: Prostate cancer (PCa) is a complex, heterogenous and multifocal disease, which is debilitating for patients and often fatal - due to bone metastasis and castration-resistant cancer. The use of murine models that mimic human disease has been crucial in the development of innovative therapies and for better understanding the mechanisms associated with initiation and progression of PCa.

Areas covered: This review presents a critical analysis of murine models for the study of PCa, highlighting their strengths, weaknesses and applications.

Expert opinion: In animal models, disease may not occur exactly as it does in humans, and sometimes the levels of efficacy that certain treatments obtain in animal models cannot be translated into clinical practice. To choose the most appropriate animal model for each research work, it is crucial to understand the anatomical and physiological differences between the mouse and the human prostate, while it is also important to identify biological similarities and differences between murine and human prostate tumors. Although significant progress has already been made, thanks to many years of research and study, the number of new challenges and obstacles to overcome mean there is a long and difficult road still to travel.

Keywords: Experimental models; prostate; rodents; tumor.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Disease Models, Animal
  • Humans
  • Male
  • Mice
  • Prostatic Neoplasms* / pathology
  • Prostatic Neoplasms, Castration-Resistant* / pathology